Novus Therapeutics (NVUS) Stock Rating Upgraded by ValuEngine - Fairfield Current

Novus Therapeutics (NVUS) Stock Rating Upgraded by ValuEngine  Fairfield Current

Novus Therapeutics (NASDAQ:NVUS) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a research report issued on Monday. Separately ...